HUP9904282A3 - Process and intermediates for preparing imidazoles as 5-lipoxygenase inhibitors - Google Patents

Process and intermediates for preparing imidazoles as 5-lipoxygenase inhibitors

Info

Publication number
HUP9904282A3
HUP9904282A3 HU9904282A HUP9904282A HUP9904282A3 HU P9904282 A3 HUP9904282 A3 HU P9904282A3 HU 9904282 A HU9904282 A HU 9904282A HU P9904282 A HUP9904282 A HU P9904282A HU P9904282 A3 HUP9904282 A3 HU P9904282A3
Authority
HU
Hungary
Prior art keywords
intermediates
lipoxygenase inhibitors
preparing imidazoles
imidazoles
preparing
Prior art date
Application number
HU9904282A
Other languages
Hungarian (hu)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HU9904282D0 publication Critical patent/HU9904282D0/en
Publication of HUP9904282A2 publication Critical patent/HUP9904282A2/en
Publication of HUP9904282A3 publication Critical patent/HUP9904282A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
HU9904282A 1998-12-22 1999-11-16 Process and intermediates for preparing imidazoles as 5-lipoxygenase inhibitors HUP9904282A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11322198P 1998-12-22 1998-12-22

Publications (3)

Publication Number Publication Date
HU9904282D0 HU9904282D0 (en) 2000-01-28
HUP9904282A2 HUP9904282A2 (en) 2000-12-28
HUP9904282A3 true HUP9904282A3 (en) 2001-04-28

Family

ID=22348241

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904282A HUP9904282A3 (en) 1998-12-22 1999-11-16 Process and intermediates for preparing imidazoles as 5-lipoxygenase inhibitors

Country Status (22)

Country Link
US (1) US6194585B1 (en)
EP (1) EP1029865B1 (en)
JP (2) JP3468729B2 (en)
KR (1) KR100362789B1 (en)
CN (1) CN1258675A (en)
AR (1) AR019497A3 (en)
AT (1) ATE265460T1 (en)
AU (1) AU6539199A (en)
BR (1) BR9905918A (en)
CA (1) CA2289422A1 (en)
CZ (1) CZ453699A3 (en)
DE (1) DE69916778D1 (en)
HU (1) HUP9904282A3 (en)
ID (1) ID24014A (en)
IL (1) IL132897A0 (en)
IN (1) IN187165B (en)
PL (1) PL337397A1 (en)
RU (1) RU2181722C2 (en)
TR (1) TR199903204A2 (en)
TW (1) TW455586B (en)
YU (1) YU59399A (en)
ZA (1) ZA997113B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4569187B2 (en) * 2004-06-17 2010-10-27 宇部興産株式会社 Process for producing 4-cyanotetrahydropyran
EP1834953A1 (en) * 2006-03-14 2007-09-19 Ranbaxy Laboratories Limited Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors
UA92833C2 (en) * 2006-11-27 2010-12-10 Пфайзер Продактс Инк. Pyrazole analogues
US11033523B2 (en) 2009-04-29 2021-06-15 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0462830B1 (en) * 1990-06-21 1995-10-18 Zeneca Limited Cyclic ether derivatives
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
EP0505122A1 (en) * 1991-03-21 1992-09-23 Zeneca Limited Alpha, alpha-dialkylbenzyl derivatives
EP0540165A1 (en) * 1991-10-03 1993-05-05 Zeneca Limited Alkanoic acid derivatives
RU2126004C1 (en) * 1993-06-14 1999-02-10 Пфайзер, Инк. Imidazole derivatives or their pharmaceutically acceptable salts
US5883106A (en) * 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
SK281577B6 (en) * 1994-10-18 2001-05-10 Pfizer Inc. Heterocyclic compositions and pharmaceutical agent based on them

Also Published As

Publication number Publication date
BR9905918A (en) 2000-09-26
PL337397A1 (en) 2000-07-03
EP1029865A2 (en) 2000-08-23
YU59399A (en) 2002-11-15
JP2000191654A (en) 2000-07-11
CZ453699A3 (en) 2000-07-12
MX9912076A (en) 2000-04-30
DE69916778D1 (en) 2004-06-03
IL132897A0 (en) 2001-03-19
EP1029865B1 (en) 2004-04-28
ID24014A (en) 2000-06-22
CN1258675A (en) 2000-07-05
AR019497A3 (en) 2002-02-20
KR100362789B1 (en) 2002-11-30
US6194585B1 (en) 2001-02-27
KR20000052537A (en) 2000-08-25
CA2289422A1 (en) 2000-06-22
IN187165B (en) 2002-02-23
HU9904282D0 (en) 2000-01-28
JP3468729B2 (en) 2003-11-17
TR199903204A2 (en) 2000-07-21
RU2181722C2 (en) 2002-04-27
JP2004002415A (en) 2004-01-08
HUP9904282A2 (en) 2000-12-28
ZA997113B (en) 2001-05-15
AU6539199A (en) 2000-06-29
TW455586B (en) 2001-09-21
ATE265460T1 (en) 2004-05-15
EP1029865A3 (en) 2000-11-08

Similar Documents

Publication Publication Date Title
AP2000001778A0 (en) Process and intermediates for preparing anti-cancer compounds
PL344108A1 (en) Process for synthesizing cox-2 inhibitors
EG23819A (en) Method for preparing of l-phenylephrine-hydrochloride
CZ20012118A3 (en) Process for preparing 3-alkanoylindole and 3-alkylindole
HUP0104482A3 (en) Method for preparing 4-hidroxyquinolines and/or tautomeric compounds
HUP0001813A3 (en) Process for preparing eprosartan and intermediates
HUP9904282A3 (en) Process and intermediates for preparing imidazoles as 5-lipoxygenase inhibitors
HUP0202315A2 (en) Process for deacylation of lipodepsipeptides
PL343487A1 (en) Process for preparing 4-substituted-1h-indole-3-glyoxamides
HUP0103002A3 (en) New process for obtaining 17betha-(n-terc-butylcarbamoyl)-3-one-4-aza-steroids
PL341752A1 (en) Method of obtaining aryloamino hydroxyantraquinones
HUP0105152A3 (en) Method for treatment of headache
HUP0003438A3 (en) Process for making 5-lipoxygenase inhibitor pirrole-carboxamid-derivatives and their intermediates
HUP0003439A3 (en) Process for making 5-lipoxygenase inhibitor pyrrole-carboxamid-derivatives and their intermediates
GB9915626D0 (en) Process and composition for water recycle
HUP0000559A3 (en) Process for preparing cyanoaceticacidesters
HU9800619D0 (en) Fermentation process
HUP0104036A3 (en) Process for preparing arylpiperidine carbinol intermediates and derivatives
AU4295100A (en) Process and intermediates for preparing benzodiazepines
EG21366A (en) Process for preparing of imidazole lipoxygenase inhibitors
PL333334A1 (en) Method of obtaining silylethenes
HU9903281D0 (en) Method for recycling of grogs
EP1119549A4 (en) Process for preparing 4-substituted-1h-indole-3-glyoxamides
PL333032A1 (en) Method of obtaining nalpha-benzyloxycarbonyl-l-lysine
PL333385A1 (en) Method of obtaining bisphenoles